Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-21
DOI
10.1038/s41416-021-01637-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum core‐type fucosylated prostate‐specific antigen index for the detection of high‐risk prostate cancer
- (2021) Kazutoshi Fujita et al. INTERNATIONAL JOURNAL OF CANCER
- Glycans as Biomarkers in Prostate Cancer
- (2019) Emma Scott et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ST3GAL3, ST3GAL4, and ST3GAL6 differ in their regulation of biological functions via the specificities for the α2,3‐sialylation of target proteins
- (2019) Feng Qi et al. FASEB JOURNAL
- O-Glycosylation–mediated signaling circuit drives metastatic castration-resistant prostate cancer
- (2018) Sheue-Fen Tzeng et al. FASEB JOURNAL
- Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality
- (2018) Richard M. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection
- (2017) Montserrat Ferrer-Batallé et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis
- (2017) Tomokazu Ishikawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aberrant sialylation of a prostate-specific antigen: Electrochemical label-free glycoprofiling in prostate cancer serum samples
- (2016) Dominika Pihikova et al. ANALYTICA CHIMICA ACTA
- Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer
- (2016) Shiro Takahashi et al. GLYCOCONJUGATE JOURNAL
- The role of glycans in the development and progression of prostate cancer
- (2016) Jennifer Munkley et al. Nature Reviews Urology
- A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer
- (2015) Dipen J. Parekh et al. EUROPEAN UROLOGY
- Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer
- (2015) Tobias Nordström et al. EUROPEAN UROLOGY
- The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
- (2015) Stacy Loeb et al. JOURNAL OF UROLOGY
- Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
- (2015) Qing Kay Li et al. Theranostics
- Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer
- (2014) Tohru Yoneyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer
- (2014) Xiangchun Wang et al. GLYCOBIOLOGY
- Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer
- (2014) Kazutoshi Fujita et al. PROSTATE
- Glycans Are a Novel Biomarker of Chronological and Biological Ages
- (2013) Jasminka Krištić et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Aberrant PSA glycosylation—a sweet predictor of prostate cancer
- (2013) Sarah Gilgunn et al. Nature Reviews Urology
- Androgen-Regulated Transcriptional Control of Sialyltransferases in Prostate Cancer Cells
- (2012) Koji Hatano et al. PLoS One
- A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia
- (2010) Miriam V. Dwek et al. CLINICA CHIMICA ACTA
- Core fucosylation and 2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia
- (2010) R. Saldova et al. GLYCOBIOLOGY
- Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells
- (2010) Koji Hatano et al. INTERNATIONAL JOURNAL OF CANCER
- Deficiency of GMDS Leads to Escape from NK Cell-Mediated Tumor Surveillance Through Modulation of TRAIL Signaling
- (2009) Kenta Moriwaki et al. GASTROENTEROLOGY
- 1,2-Fucosylated and -N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer
- (2009) K. Fukushima et al. GLYCOBIOLOGY
- Glycoproteomics for Prostate Cancer Detection: Changes in Serum PSA Glycosylation Patterns
- (2008) Danni L. Meany et al. JOURNAL OF PROTEOME RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More